Is China Pharma Holdings Inc (CPHI) overvalued? · rev $4.5M
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
This page asks whether China Pharma Holdings Inc (CPHI) looks expensive on cached numbers — not a short thesis.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
CPHI currently screens at market cap $29.0M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CPHI 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CPHI stock page for the full model, not this heading.
Not investment advice.